tert-Butyl 4-acetyl-2,2-dimethyloxazolidine-3-carboxylate

Catalog No. :
ACBGJX938
CAS No. :
433683-01-3
Molecular Formula :
C12H21NO4
Molecular Weight :
243.30

IUPAC Name:tert-butyl 4-acetyl-2,2-dimethyloxazolidine-3-carboxylate

tert-Butyl 4-acetyl-2,2-dimethyloxazolidine-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$62.00Login to see priceInquiryInquiry
250mg95%$78.00Login to see priceInquiryInquiry
1g95%$137.00Login to see priceInquiryInquiry
5g95%$467.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-acetyl-2,2-dimethyloxazolidine-3-carboxylate
IUPAC Nametert-butyl 4-acetyl-2,2-dimethyloxazolidine-3-carboxylate
MDL No.T193403
Molecular FormulaC12H21NO4
Molecular Weight243.30
SMILESO=C(N1C(C)(C)OCC1C(C)=O)OC(C)(C)C
InChI KeyOBEQVSYPZVGBHL-UHFFFAOYSA-N
Synonymtert-Butyl 4-acetyl-2,2-dimethyloxazolidine-3-carboxylate | 433683-01-3 | tert-Butyl 4-acetyl-2,2-dimethyl-1,3-oxazolidine-3-carboxylate | SCHEMBL3616475 | tert-Butyl4-acetyl-2,2-dimethyloxazolidine-3-carboxylate | DTXSID80616209 | MFCD20232837 | AKOS016004950 | DS-2468 |
CAS No.433683-01-3
PubChem CID21593766

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACBGJX938 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBGJX938 route product structure diagram
    ACBGJX938433683-01-3
Inquiry

2. ACBGJX938 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBGJX938 route product structure diagram
    ACBGJX938433683-01-3
Inquiry

Comments (0)